z-logo
open-access-imgOpen Access
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Author(s) -
Mark McCormack,
Ana Alfirevic,
Stéphane Bourgeois,
John Farrell,
Dalia Kasperavičiūtė,
Mary Carrington,
Graeme J. Sills,
Anthony G Marson,
Xiaoming Jia,
Paul I. W. de Bakker,
Krishna Chinthapalli,
Mariam Molokhia,
Michael Johnson,
Gerard D. O’Connor,
Elijah Chaila,
Saud Alhusaini,
Kevin V. Shianna,
Rodney A. Radtke,
Erin L. Heinzen,
Sophie Nicole,
Massimo Pandolfo,
Werner J. Pichler,
B. Kevin Park,
Chantal Depondt,
Sanjay M. Sisodiya,
David B. Goldstein,
Panos Deloukas,
Norman Delanty,
Gianpiero L. Cavalleri,
Munir Pirmohamed
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1013297
Subject(s) - carbamazepine , odds ratio , medicine , allele , toxic epidermal necrolysis , human leukocyte antigen , immunology , genotyping , dermatology , genotype , genetics , epilepsy , biology , antigen , gene , psychiatry
Carbamazepine causes various forms of hypersensitivity reactions, ranging from maculopapular exanthema to severe blistering reactions. The HLA-B*1502 allele has been shown to be strongly correlated with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) in the Han Chinese and other Asian populations but not in European populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom